BusinessOncothyreon Appoints Scott D. Myers Chief Executive OfficerBy Nasdaq OMXMar 29, 2016, 12:00 PM UTC
BusinessNeothetics Reports Fourth Quarter 2015 Financial ResultsBy Nasdaq OMXMar 29, 2016, 12:00 PM UTC
BusinessCaladrius Biosciences Announces First Subject Treated in CLBS03 Type 1 Diabetes Phase 2 TrialBy Nasdaq OMXMar 29, 2016, 11:30 AM UTC
BusinessWorld Stem Cell Summit & RegMed Capital Conference Returns to West Palm BeachBy Nasdaq OMXMar 28, 2016, 6:08 PM UTC
BusinessNeothetics Provides Update and Plan Forward for LIPO-202 ProgramBy Nasdaq OMXMar 28, 2016, 12:00 PM UTC
BusinessApricus Reports Top-Line Phase 2b Data for Fispemifene in Symptomatic Secondary HypogonadismBy Nasdaq OMXMar 28, 2016, 11:00 AM UTC
TechnologyIf we don't own our genes, what protects study subjects in genetic research?By Erin Fuse BrownMar 28, 2016, 10:45 AM UTC
